Our business is breakthroughs

We take cutting-edge innovations from the lab bench to the bedside, translating them into effective tools, treatments and diagnostics for people with cancer.

 

Find out more
Scientist working in a lab

14

marketed drugs

£600m+

revenue from royalties and IP

150+

active licences

90+

start-ups

£3bn+

raised by our start-up portfolio

Innovate and work with us

Image of a smiling scientist

Researchers

We support innovative research that can benefit society. Let us help you turn your ideas into meaningful progress for patients.

A person sat at a desk, short hair, glasses and short sleeved shirt wearing a lanyard, looking at the person next to them

Partners

We de-risk innovation by turning promising science into high-value assets. Partner with us for access to our extensive network and portfolio.

Investors image

Investors

We invest and co-invest in societal progress, and in the people who can turn ideas into a business reality. Explore investment opportunities with us.

Two men stand in a library setting. The man on the left wears a blue checked blazer, while the man on the right wears glasses and a dark jacket. Both have lanyards. Bookshelves are visible in the background.

Introducing our expert network

Entrepreneur support

Our world-class expert network, drawn from our extensive research community and partners, comprises leading business, scientific, clinical, investment, and industry experts across the oncology sector. 

 

Learn more
A man wearing glasses and a blue blazer sits at a booth, deep in conversation with someone off-frame. He wears a lanyard with the Cancer Research Horizons logo on it.

The cutting-edge of translational oncology - directly to your inbox

Sign up to our newsletter

Receive quarterly updates featuring expert insights on emerging trends and thought leadership from those shaping the future of oncology innovation, specifically hand-picked by our team.  

You’ll also get the latest on our work in drug discovery, clinical trials, licensing, partnerships, and investment – all in a clear, digestible format. 

Subscribe here

Latest news

FGC scientists in the lab

Drug discovery and development capabilities

Spotlight

We're committed to driving therapeutic innovation in oncology, with six drug discovery sites and one focus: accelerating the discovery and development of new therapeutics. Our expertise spans target identification, validation and clinical positioning, through Hit identification and lead optimisation to the selection of candidate drugs for regulatory development, for both small molecule and antibody modalities.

Through partnership with the Cancer Research UK Centre for Drug Development we can also offer access to the capabilities and infrastructure needed to demonstrate clinical potential.

Explore our capabilities

Our portfolio

Scientist with a beard using a pipette

Explore our pipeline

We've played a role in delivering 14 new cancer treatments for patients. Explore our clinical and preclinical assets currently in development.

A woman sitting in front of a laptop

Licensing opportunities

Discover the innovations we have available for collaboration, that will help create the medicines of tomorrow.

Three people in discussion sat at a table

Our start-up portfolio

With a growing portfolio of start-ups, we're bringing together the community to spark the next breakthrough in cancer research.